BMO Capital Starts Neos Therapeutics (NEOS) at Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/25/2026
- Nasdaq, S&P end lower as tech stocks fall
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
RBC Capital Starts Neos Therapeutics (NEOS) at Outperform
August 17, 2015 7:38 AM EDTRBC Capital initiated coverage on Neos Therapeutics (NASDAQ: NEOS) with an Outperform rating and a price target of $35.00.
For an analyst ratings summary and ratings history on Neos Therapeutics click here. For more ratings news on Neos Therapeutics click here.
Shares of Neos Therapeutics closed at $20.63 yesterday.
... MoreJMP Securities Starts Neos Therapeutics (NEOS) at Market Outperform
August 17, 2015 7:37 AM EDTJMP Securities initiated coverage on Neos Therapeutics (NASDAQ: NEOS) with a Market Outperform rating and a price target of $32.00.
For an analyst ratings summary and ratings history on Neos Therapeutics click here. For more ratings news on Neos Therapeutics click here.
Shares of Neos Therapeutics closed at $20.63 yesterday.
... More